{"filings":[{"id":1249358,"accession_number":"0001816431-26-000046","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2026-06-24T20:06:09+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Quantum-Si signs 10-year lease for 54,374 sq ft San Diego facility; $315/sq ft tenant improvement allowance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Lease for 54,374 sq ft at 9955 Pacific Heights Blvd, San Diego; initial monthly base rent $315,369 ($5.80/sq ft) with 3% annual escalations.","Rent abated for first 20 months; term 120 months starting on or before Nov 1, 2027.","Landlord provides tenant improvement allowance of up to $17.1M ($315/sq ft) and a $19.5M letter of credit to fund construction.","Lease supports Proteus platform development and expanded manufacturing; transition from existing San Diego lease expiring Dec 31, 2027.","Security deposit of ~$2.1M in letter of credit; prepaid rent of $434,448."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":471036,"accession_number":"0001816431-26-000037","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2026-05-15T20:14:08+00:00","items":["5.07"],"status":"ready","headline":"Quantum-Si shareholders reelect all 10 directors, ratify auditor, approve say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 10 director nominees elected with >444M votes for each; highest for Jonathan Rothberg (454M for).","Ratification of PricewaterhouseCoopers as auditor: 502.4M for, 0.8M against, 0.3M abstain.","Advisory say-on-pay approved: 441.3M for, 13.0M against, 0.2M abstain.","Broker non-votes of ~48.9M shares on director and say-on-pay proposals (not on auditor ratification).","Quorum achieved with ~84.6% of total voting power (104.7M Class A + 19.9M Class B shares)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95707,"accession_number":"0001816431-26-000032","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si Q1 net loss widens to $21.7M; Proteus sequencing milestones on track","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $258,000, gross margin 29%; net loss $21.7M vs $19.2M YoY.","Adjusted EBITDA negative $20.1M; adjusted operating expenses $21.4M.","Achieved automated sequencing runs on integrated Proteus instruments.","Current kit detects 17 amino acids; first customer samples sequenced on prototype.","Anticipates commercial launch end of 2026; early access sites this summer."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":258000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108970,"accession_number":"0001816431-26-000009","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si reports Q4 2025 revenue of $451k, announces Proteus list price of $425k, and provides 2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Fourth quarter 2025 revenue was $451,000, gross margin 27%, and net loss $17.6 million.","Company announced list price for Proteus platform at $425,000 and reiterated on track for year-end 2026 launch.","Full year 2026 revenue guidance of approximately $1.0 million, adjusted operating expenses $98 million or less, total cash usage $93 million or less.","Cash and investments as of Dec 31, 2025: $215.8 million, expected to fund operations into Q2 2028.","Legacy litigation charges of $18.7 million impacted 2025 results."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125424,"accession_number":"0001816431-25-000074","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-12-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Quantum-Si Incorporated posts updated corporate presentation on December 29, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company posted updated corporate presentation on its website on December 29, 2025.","Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.","Presentation slides available on 'Investors' section at https://ir.quantum-si.com.","Presentation provides updates and summaries of Quantum-Si's business to investment community."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125423,"accession_number":"0001816431-25-000071","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-11-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Quantum-Si targets Proteus launch in Q4 2026 with 20-AA detection by 2027","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Proteus product launch set for YE2026; first integrated system expected Q1 2026.","Sequencing kit V4 detects 14 of 20 amino acids; path to 18 at launch, all 20 by 2027.","Partnerships with Carna Biosciences (kinase profiling) and Siena Quant (ultra-low-abundance biomarkers).","Proteus architecture yields superior SNR and alignment output vs Platinum; 80M wells per consumable.","Recognizer pipeline scaling 4× using AI, rational design, and combinatorial methods; 8 dyes demonstrated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125422,"accession_number":"0001816431-25-000065","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si reports Q3 2025 revenue of $552K, net loss $35.7M; Proteus prototype sequencing successful","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $552K; gross profit $194K, gross margin 35%.","Net loss $35.7M vs $25.3M YoY; adjusted EBITDA -$20.1M vs -$24.5M YoY.","Successfully demonstrated sequencing on prototype Proteus system; development on track for H2 2026 launch.","Launched v4 Sequencing Kit in early Sept; v3 Library Prep Kit for low-input samples on track for year-end 2025.","Adjusted total operating expenses $21.4M, down from $26.0M YoY; company manages costs while funding Proteus."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.44,"consensus_revenue_estimate":null,"consensus_revenue_actual":1985000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142161,"accession_number":"0001140361-25-036498","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Quantum-Si enters $100M at-the-market equity offering agreement with Leerink Partners","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["May offer and sell up to $100M of Class A common stock at its discretion through Leerink Partners as sales agent.","Sales may be made in at-the-market offerings under Rule 415(a)(4); Company has no obligation to sell any shares.","Leerink Partners will receive up to 3.0% commission on gross proceeds; Company also reimburses up to $75k in legal expenses.","Shelf registration statement on Form S-3 filed concurrently on Sept. 26, 2025; effectiveness required before any sales.","Agreement may be terminated by either party at any time upon written notice."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142160,"accession_number":"0001816431-25-000060","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-09-26T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"Quantum-Si pays $11M to settle lease litigation and terminate New Haven lease","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Settles lawsuit with landlord Winchester Office LLC; terminates lease at 115 Munson St, New Haven effective Sept 23, 2025.","Total settlement payment of $11M; net of $573k security deposit forfeiture and $273k Sep rent credit, cash payment $10.15M due Sep 26.","Lease originally ran to July 2032; early exit removes future rent obligations but requires large near-term cash outlay.","Confidentiality and non-disparagement terms agreed; company retains right to disclose to SEC as required."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142159,"accession_number":"0001816431-25-000056","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-08-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Quantum-Si furnishes updated corporate presentation; no material changes disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Corporate presentation posted to investors section of company website on August 8, 2025.","Presentation furnished as Exhibit 99.1, but no specific financial or operational updates are provided in the filing.","Filing is procedural under Regulation FD; no new guidance, metrics, or events are reported.","No material information beyond routine investor presentation update is available."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142158,"accession_number":"0001816431-25-000048","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si Q2 revenue $591K, net loss $28.8M; raises $50M cash runway","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2025 revenue $591K; gross margin 59%; net loss $28.8M vs $23.1M prior year.","Six-month 2025 revenue $1.4M, up 33% YoY; adjusted EBITDA -$22.2M in Q2.","Raised $50M in registered direct offering; cash runway extended into Q2 2028.","Proteus platform on track; v4 Sequencing Kit launch expected Q3 2025.","NIH funding headwinds slowed capital sales; new instrument acquisition options launched."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":1433000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142157,"accession_number":"0001140361-25-025059","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-07-07T23:59:59+00:00","items":["1.01","1.02","8.01","9.01"],"status":"ready","headline":"Quantum-Si prices $50M registered direct offering of stock and pre-funded warrants at $1.67","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$50M from sale of 29,940,119 shares (including pre-funded warrants) at $1.67 per share.","Offering expected to close July 8, 2025, subject to customary conditions.","Proceeds to fund product development, commercialization, manufacturing, R&D, and working capital.","Terminates existing ATM equity distribution agreement with Canaccord Genuity, which had sold 23.4M shares for $36.2M.","A.G.P./Alliance Global Partners acts as sole placement agent, receiving a 6.0% cash fee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160149,"accession_number":"0001140361-25-019766","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Quantum-Si shareholders reelect 10 directors, ratify PwC, approve say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 10 director nominees reelected; each received over 99% of votes cast excluding broker non-votes.","Ratification of PricewaterhouseCoopers as auditor for FY2025 passed with 99.7% of votes cast.","Advisory vote on named executive officer compensation approved with 99.6% of votes cast."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160148,"accession_number":"0001816431-25-000038","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-05-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si Q1 revenue $842K (+84% YoY); launches Platinum Pro, cash runway to H2 2027","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $842K (+84% YoY); gross profit $486K, gross margin 58%.","Net loss $19.2M (vs $19.5M YoY); adj. total opex $22.9M; adj. EBITDA -$21.5M.","Launched and delivered first Platinum Pro units; v4 Sequencing Kit on track for Q3 2025 launch.","Announced development of v3 Library Preparation Kit with expected launch by end of 2025.","Expanded international channel network to 23 partners; cash runway into H2 2027 reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":842000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160147,"accession_number":"0001816431-25-000032","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-04-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Quantum-Si posts updated corporate presentation on website, no new material details disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Filed under Item 7.01 Regulation FD; presentation furnished as Exhibit 99.1.","Presentation available on the 'Investors' section of https://ir.quantum-si.com.","No specific operational or financial updates provided in the filing text.","Content of the presentation slides was not included; only title and disclaimer pages visible."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178466,"accession_number":"0001816431-25-000011","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si Q4 revenue $1.2M, full year $3.1M (+183% YoY); raises $86M, extends cash runway to H2 2027","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1.2M Q4 2024, $3.1M full year 2024 (+183% YoY). Gross margin 51% Q4, 52% FY.","Net loss $33.1M Q4 vs $22.0M prior year; FY net loss $101.0M vs $96.0M prior year.","Raised over $86M in capital between Q4 2024 and early 2025, extending cash runway into H2 2027.","Launched Platinum Pro instrument in Jan 2025; v4 Sequencing Kit on track for Q3 2025 launch.","Restructuring program in Q4 2024 to streamline resources; adjusted operating expenses flat YoY at ~$99M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178465,"accession_number":"0001140361-25-000295","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2025-01-06T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Quantum-Si prices $50M registered direct offering of 15.6M shares at $3.20 each","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 15,625,000 shares at $3.20/share; gross proceeds ~$50M; closing expected Jan 6, 2025.","Net proceeds for working capital, general corporate purposes, and Proteus platform development.","A.G.P./Alliance Global Partners serving as sole placement agent with 6.0% cash fee.","Lock-up provision: Company cannot issue additional shares or file S-3 for 45 days post-closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195137,"accession_number":"0001140361-24-048977","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-12-11T23:59:59+00:00","items":["1.01","1.02","9.01"],"status":"ready","headline":"Quantum-Si enters $75M ATM equity facility with Canaccord; ends prior Evercore deal","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Enters Equity Distribution Agreement with Canaccord Genuity for up to $75M of Class A common stock.","Canaccord will receive up to 3.0% commission on gross sales price per share sold in at-the-market offerings.","Terminates prior ATM agreement with Evercore Group L.L.C. dated August 11, 2023; no shares were sold under that agreement.","Shares will be sold under existing S-3 shelf registration effective August 22, 2023.","Company has no obligation to sell any shares and may suspend or terminate the agreement at any time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195136,"accession_number":"0001140361-24-048732","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-12-09T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Quantum-Si regains Nasdaq minimum bid price compliance; delisting risk lifted for now","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received notice on Nov 4, 2024 that common stock bid price closed below $1.00 for 30 consecutive days; non-compliance with Nasdaq Listing Rule 5450(a)(1).","As of Dec 4, 2024, company regained compliance per Nasdaq Staff notification on Dec 5, 2024; matter closed.","Company will continue to monitor bid price; future non-compliance could lead to delisting notice."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195135,"accession_number":"0001140361-24-047639","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-11-22T23:59:59+00:00","items":["2.05"],"status":"ready","headline":"Quantum-Si to cut ~23% of workforce in restructuring; expects $2.6M in charges","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Terminating approximately 23% of 187 employees; restructuring to streamline resources.","Expected one-time cash charges of ~$2.3M in 2024 and ~$0.3M in first half 2025.","Non-cash expense of ~$0.2M in 2024 related to stock option modifications.","Restructuring substantially complete in Q4 2024; aligns with Proteus platform focus."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195134,"accession_number":"0001140361-24-047429","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-11-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Quantum-Si holds Investor & Analyst Day; no specific new details in furnished presentation","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company presented at Investor & Analyst Day on November 20, 2024; slides furnished as Exhibit 99.1.","Presentation content is not fully available in this filing; only title slide shown.","No financial results, guidance, or material business updates disclosed in the 8-K or exhibit snippet.","Investors are directed to the company's website for the complete presentation and webcast replay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195133,"accession_number":"0001816431-24-000013","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si Q3 revenue $787k; CEO warns full-year revenue guidance unlikely","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2024 revenue $787k, gross margin 47%; net loss $25.3M vs $24.7M a year ago.","CEO says full-year guided revenue of $3.7-$4.2M unlikely due to lengthening sales cycles.","New library prep and barcoding kits remain on track for Q4 launch.","Appointed Todd Bennett as CCO, John Vieceli as Chief Product Officer, Lindsay Thompson as CHRO.","Adjusted EBITDA negative $24.5M in Q3 vs negative $22.6M a year ago."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.48,"consensus_revenue_estimate":null,"consensus_revenue_actual":1866000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195131,"accession_number":"0001816431-24-000018","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K/A","filed_at":"2024-11-12T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Quantum-Si corrects compliance date for Nasdaq bid price deficiency to May 5, 2025","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Quantum-Si on Nov 4, 2024 that bid price below $1.00 for 30 consecutive days.","Original 8-K incorrectly listed compliance date as May 5, 2024; corrected to May 5, 2025.","To regain compliance, closing bid price must be at least $1.00 for minimum of 10 consecutive business days.","If not compliant by May 5, 2025, company may seek additional 180-day period by transferring to Nasdaq Capital Market.","Company will consider available options but cannot assure compliance will be achieved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195132,"accession_number":"0001816431-24-000009","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-11-08T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Quantum-Si receives Nasdaq bid price deficiency notice; must regain compliance by May 5, 2024","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Closing bid price of Class A common stock (QSI) below $1.00 for 30 consecutive business days as of Nov 4, 2024.","Company has 180 days, until May 5, 2024, to regain compliance with minimum bid price of $1.00 for 10 consecutive days.","If not compliant by May 5, may transfer to Nasdaq Capital Market for additional 180-day cure period, subject to meeting other standards.","Stock continues trading on Nasdaq Global Market under QSI; no immediate impact on operations or SEC reporting.","Company intends to monitor bid price and consider available options; no assurance of regaining compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211404,"accession_number":"0001140361-24-038744","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-08-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quantum-Si appoints Bennett as CCO, Vieceli as CPO, Thompson as CHRO; Johnston resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Todd Bennett appointed Chief Commercial Officer effective Sept 17, 2024; Grace Johnston resigns effective Sept 6.","John Vieceli named Chief Product Officer; Lindsay Thompson named Chief Human Resources Officer.","Bennett receives inducement stock options ($500K grant-date fair value) and RSUs ($500K), vesting 25% at one year then quarterly.","Bennett brings 30+ years commercial leadership from Luminex, Abbott, Roche, and Immucor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211403,"accession_number":"0001140361-24-036909","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-08-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Quantum-Si posts updated corporate presentation with no material new details","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company made updated corporate presentation available on its website on August 12, 2024.","Presentation was furnished as Exhibit 99.1 to this 8-K, but no specific financial or operational updates are disclosed in the filing.","No earnings, guidance, or other material events are included in the filing's text.","Investors are directed to the 'Investors' section of the company's website for the full presentation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211402,"accession_number":"0001628280-24-035608","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si Q2 2024 revenue $622K, net loss narrows to $23.1M; launches v3 sequencing kit","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $622K, gross margin 57%; net loss $23.1M vs $25.6M YoY.","Adjusted EBITDA -$22.6M; operating expenses $26.8M.","Launched version 3 sequencing kit; expects v2 library prep and barcoding kit by end of 2024.","Appointed Chuck Kummeth as independent Chairman."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":1079000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230037,"accession_number":"0001140361-24-031295","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-06-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Quantum-Si posts updated corporate presentation to website","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Updated presentation made available on ir.quantum-si.com on June 25, 2024.","Presentation likely covers business strategy and updates; no quantitative data provided in the filing.","No other material events reported in this 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230036,"accession_number":"0001140361-24-029281","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-06-07T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Quantum-Si dismisses Deloitte, appoints PwC as auditor; discloses prior material weaknesses","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Appointed PwC as independent auditor for FY2024, effective June 4, 2024, subject to client acceptance.","Dismissed Deloitte; no disagreements on accounting principles in fiscal years 2022 and 2023.","Disclosed material weaknesses from 2022: inaccurate warrant accounting and lack of in-house finance expertise.","Deloitte's letter agreeing with disclosures filed as Exhibit 16.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230035,"accession_number":"0001140361-24-028135","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-05-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quantum-Si appoints former Bio-Techne CEO Chuck Kummeth as independent Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kummeth, former Bio-Techne CEO for 11 years, elected independent Chairman effective May 27, 2024.","Board expanded from 9 to 10 members; Jonathan Rothberg remains director, steps down as Chair.","Kummeth received one-time grant of options to purchase 527,777 shares ($570K fair value, 3-year vest).","Under Kummeth, Bio-Techne revenue grew from $300M to $1.1B and market cap from $2.2B to $21B.","Kummeth also serves on boards of Gentherm, PerkinElmer, Orthofix."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230034,"accession_number":"0001140361-24-027450","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Quantum-Si discloses shareholder class action lawsuit over SPAC merger process","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Lawsuit filed May 16, 2024 in Delaware Court of Chancery; plaintiff Farzad v. HighCape Capital, et al.","Claims include breach of fiduciary duty against former HighCape officers/directors; aiding and abetting against Foresite Capital and Jonathan Rothberg.","Suit alleges unfair process and mispricing in the business combination that formed Quantum-Si.","Seeks unspecified damages, attorneys' fees; no assurance of successful defense or insurance coverage."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230033,"accession_number":"0001140361-24-026703","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-05-17T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Quantum-Si stockholders approve charter amendment removing director cap and adding Class B sunset on June 10, 2028","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Charter amendment approved: removes director cap (460,048,611 for, 401,937 against) and adds automatic Class B conversion on June 10, 2028 (398,750,000 Class B votes for, 0 against).","Nine directors re-elected; Jack Kenny (449,949,474 for) and Kevin Rakin (448,510,967 for) received most opposition.","Deloitte & Touche ratified as auditor for FY2024 (460,397,267 for, 71,110 against); say-on-pay approved (459,462,890 for, 907,087 against).","Quorum was 88.45% of total voting power; Class B common stock held 20 votes per share.","Certificates of amendment filed with Delaware on May 16, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230032,"accession_number":"0001140361-24-025182","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si reports Q1 revenue $457K, net loss $19.5M; launches Platinum instrument","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $457,000; gross profit $269K at 59% margin.","Net loss $19.5M (vs $23.6M Q1 2023); adjusted EBITDA -$20.5M.","Full commercial launch of Platinum instrument started end of March 2024.","Version 3 sequencing kit on track for launch by end of Q3 2024.","Paula Dowdy added to Board; FY2024 financial guidance reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":457000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230031,"accession_number":"0001140361-24-018902","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-04-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Quantum-Si posts updated corporate presentation; no specific data extracted from exhibit","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Corporate presentation posted to investors section of company website on April 9, 2024.","Exhibit 99.1 content not provided in filing review; no financial or operational metrics available.","No earnings, M&A, leadership changes, or other material events disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248478,"accession_number":"0001140361-24-014618","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-03-21T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quantum-Si appoints former Illumina executive Paula Dowdy to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Paula Dowdy appointed to board effective March 21, 2024.","She has over 35 years experience including SVP/GM EMEA at Illumina and 20+ years at Cisco.","Board determined Dowdy is independent under Nasdaq rules; she will receive standard non-employee director compensation.","Dowdy also serves on SPT Labtech board and advises EQT Life Sciences."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248477,"accession_number":"0001140361-24-012640","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-03-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Quantum-Si amends CEO and CFO stock options with price-based vesting at $6-$12","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Jeffrey Hawkins: 1.5X Option (1.39M shares) and 3.5X Option (1.39M shares) amended with new performance vesting conditions.","CFO Jeffry Keyes: 1X Option (500K shares) and 3X Option (500K shares) amended with similar vesting price targets.","Vesting triggers: stock closing price ≥$6, $8, $10, or $12 for 20 of 30 consecutive trading days within 3 years from March 15, 2024.","Amendments effective March 15, 2024, designed to align executive incentives with stock price performance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248476,"accession_number":"0001140361-24-010435","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-02-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si Q4 rev $400k, net loss $22M; full commercial launch expected by end Q1 2024","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $400k in Q4 2023, $1.1M for FY2023; gross margin 45%.","Net loss narrowed to $22.0M in Q4 ($96.0M FY) from $33.1M ($132.4M FY) prior year.","Expects full commercial launch of Platinum instrument by end of Q1 2024; version 2 sequencing kit already shipping.","Version 3 sequencing kit planned for release by end of Q3 2024.","Third international distribution partner TOMY Digital Biology (Japan) added."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":1082000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248475,"accession_number":"0001140361-24-005543","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2024-02-05T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Quantum-Si launches V2 Sequencing Kits with 3-fold cost reduction, new amino acid recognizer","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["V2 Sequencing Kit adds new amino acid recognizer, improved surface chemistry, reagents, and software.","Approximately 3-fold reduction in cost per amino acid for protein sequencing.","Enhancements enable increased sequencing output, high reproducibility, and identification of unknown proteins.","Platform now supports peptide barcodes and new sample types, expanding potential applications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265978,"accession_number":"0001140361-23-052467","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si Q3 2023: $223k revenue, $24.7M net loss; controlled launch continues","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $223,000; gross profit $108,000 (48% margin); net loss $24.7M vs. $31.7M YoY.","Adjusted EBITDA loss of $22.6M; adjusted operating expenses $23.9M.","Completed R&D strategic review; focused on delivering capabilities with highest customer demand.","First customer data presented; full commercial launch of Platinum instrument expected early 2024.","Appointed Amir Jafri as independent director, strengthening Board."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":682000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283203,"accession_number":"0001140361-23-044686","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-09-21T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quantum-Si appoints biotech executive Amir Jafri to board of directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Amir Jafri appointed to Board, effective September 22, 2023; Board size increased from 8 to 9.","Jafri is founder, President and CEO of Immunicom, a clinical-stage biotech company.","Board determined Jafri is independent under Nasdaq rules; standard non-employee director compensation applies.","John Patrick (Jack) Kenny appointed Chairperson of the Nominating and Corporate Governance Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283202,"accession_number":"0001140361-23-042737","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-09-05T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quantum-Si COO Patrick Schneider departs; separation agreement provides $356,250 and partial option vesting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Employment terminated August 31, 2023; separation pay of $356,250 lump sum.","291,666 stock options vest; remaining 2,408,334 unvested options forfeited.","Company to pay COBRA health premiums through May 31, 2024, or until new coverage.","Separation includes standard release, non-disparagement, and cooperation clauses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283201,"accession_number":"0001140361-23-041635","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-08-29T23:59:59+00:00","items":["2.05","5.02"],"status":"ready","headline":"Quantum-Si announces 16% workforce reduction; President/COO Schneider departs","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Restructuring to cut ~16% of workforce; expects $2.5M cash severance charge and $0.3M non-cash stock option modification expense in H2 2023.","President and COO Patrick Schneider steps down effective August 28, 2023; separation agreement to follow.","CEO Jeffrey Hawkins appointed as President in addition to his CEO role; no additional compensation.","Restructuring aimed at decreasing costs and streamlining organization; expected to complete in Q4 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283200,"accession_number":"0001140361-23-038175","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si Q2 revenue $205k, net loss $25.6M, cash runway into 2026","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $205,000 from Platinum instruments and consumables; gross margin 38.0%.","Net loss $25.6M narrowed from $32.4M YoY; adjusted EBITDA negative $22.9M.","Cash and securities $297.2M; reiterates non-GAAP opex flat YoY, runway into 2026.","Added Jeff Keyes as CFO and Johan Denecke as SVP Operations; board members Scott Mendel and Jack Kenny.","Initiated strategic review of R&D programs; expects changes in Q3 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":459000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283199,"accession_number":"0001140361-23-035248","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-07-20T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quantum-Si EVP McKenna to separate effective July 31, 2023; receives $337,500 severance","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Michael P. McKenna, EVP Product Development and Operations, leaves on July 31, 2023.","Separation pay of $337,500 (9 months severance) plus COBRA coverage through April 30, 2024.","227,083 stock options vest; 747,656 RSA and 44,862 RSUs vest; remaining 622,917 options and 34,888 RSUs forfeited.","Agreement includes standard release, non-disparagement, and cooperation clauses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302611,"accession_number":"0001140361-23-030639","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-06-21T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quantum-Si appoints Johan Denecke as SVP of Operations; EVP Michael McKenna to depart July 31","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Johan Denecke named SVP of Operations, effective June 20, 2023, responsible for scaling production and operational excellence.","Michael McKenna, Ph.D., will step down as EVP of Product Development and Operations, effective July 31, 2023, by mutual agreement.","Denecke previously held senior operations roles at Illumina, Thermo Fisher Scientific, and Atomica.","McKenna’s separation terms will align with the company’s Executive Severance Plan.","Appointment aims to support commercialization of Quantum-Si’s single-molecule protein sequencing platform."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302610,"accession_number":"0001140361-23-028655","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-06-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quantum-Si CFO Claudia Drayton to depart June 30; receives $300K severance, partially vested equity","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Claudia Drayton stepped down as CFO on May 12, 2023; will serve as senior advisor until termination on June 30, 2023.","Separation agreement provides $300,000 lump-sum severance payment and COBRA coverage through March 31, 2024.","229,037 stock options and 47,852 restricted stock units vest; remaining 612,362 options and 47,848 RSUs forfeited.","Company agrees not to contest unemployment claims; Drayton releases all claims against Quantum-Si."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302609,"accession_number":"0001140361-23-025888","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-05-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quantum-Si appoints Jack Kenny to Board of Directors, effective May 19, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jack Kenny, CEO of Meridian Bioscience, appointed to Quantum-Si board effective May 19, 2023.","He will serve on the Nominating and Corporate Governance and Compensation Committees.","Mr. Kenny brings over 30 years of operational and commercial leadership in healthcare and diagnostics.","He is considered independent under Nasdaq rules and will receive standard nonemployee director compensation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302608,"accession_number":"0001140361-23-025021","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-05-16T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Quantum-Si stockholders approve charter amendment limiting officer liability and reelect directors at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Charter Amendment limiting officer liability under Delaware law approved by shareholders (444.98M for, 6.55M against).","All seven director nominees re-elected with overwhelming support (e.g., Rothberg 437.3M for, Mendel 451.0M for).","Deloitte & Touche ratified as auditor for FY 2023 with 477.4M votes for; say-on-pay approved with 446.0M for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302607,"accession_number":"0001140361-23-024152","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-05-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Quantum-Si Q1 revenue $254K, orders $449K; appoints Jeff Keyes CFO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2023 revenue $254,000 on orders of $449,000; gross margin 48.8%.","Net loss $23.6M vs $35.2M YoY; adjusted EBITDA -$23.7M.","Cash and investments $322.1M; runway into 2026.","Appointed Jeff Keyes as CFO effective May 15, 2023.","Expects revenue acceleration in H2 2023 based on robust business funnel."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":254000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302606,"accession_number":"0001140361-23-022308","cik":1816431,"company_name":"Quantum-Si Inc","ticker":"QSI","form_type":"8-K","filed_at":"2023-05-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Quantum-Si names Jeffry Keyes CFO; Claudia Drayton steps down effective May 15, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeffry Keyes appointed CFO and Treasurer; start date on or before May 15, 2023.","Claudia Drayton steps down from CFO/Treasurer roles on Appointment Date, serves as advisor through June 30, 2023.","Keyes receives $465,000 base salary, 50% target bonus, and inducement equity awards of 2 million stock options.","Inducement awards: 1M time-based options (4-year vest), 500K performance options at $10/share, 500K at $20/share.","Keyes brings 25+ years CFO experience at Spinal Elements, Custopharm, and other life science companies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":246068993.56481475,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-05-02T23:59:59+00:00|302606"}